Angiodynamics (ANGO) Capital Expenditures Growth (1y) (2011 - 2026)
Angiodynamics (ANGO) Capital Expenditures Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -27.50% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -12.80% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 19.11% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 67.16% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 0.91% |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -42.55% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -24.55% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 10.63% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -17.14% |
| 10 | Angiodynamics | 655.49 Mn | 601.62 Mn | 46.77 Mn | -88.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -46.85% |
| Feb 28, 2026 | -16.12% |
| Nov 30, 2025 | -63.75% |
| Aug 31, 2025 | -44.33% |
| May 31, 2025 | 37.28% |
| Feb 28, 2025 | 99.34% |
| Nov 30, 2024 | 101.38% |
| Aug 31, 2024 | 71.19% |
| May 31, 2024 | 150.99% |
| Feb 29, 2024 | -78.57% |
| Nov 30, 2023 | 521.90% |
| Aug 31, 2023 | -65.56% |
| May 31, 2023 | -206.83% |
| Feb 28, 2023 | 156.06% |
| Nov 30, 2022 | -112.11% |
| Aug 31, 2022 | 118.12% |
| May 31, 2022 | 67.58% |
| Feb 28, 2022 | -75.78% |
| May 31, 2021 | -58.08% |
| Feb 28, 2021 | 162.17% |